A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say. To be sure, drugs such as$诺和诺德 (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...
Penumbra股票讨论
To be sure, drugs such as $诺和诺德 (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...
猜涨跌 上涨
1. $Vertiv Holdings (VRT.US)$ 涨了18.6%
2. $伊瑞保险 (ERIE.US)$ 涨了8.7%
3. $艾斯本科技 (AZPN.US)$ 涨了6.5%
4. $潘世奇汽车 (PAG.US)$ - up 4.1%
5. $哈门那 (HUM.US)$ 涨幅为3.7%
6. $梯瓦制药 (TEVA.US)$ 涨幅为3.7%
7. $Encompass Health (EHC.US)$ - 猜涨跌0.4%
8. $艾默生电气 (EMR.US)$ 猜涨跌2.8...
销售额和收益都是公司成功的关键因素。因此,仅按照一个增长指标对公司进行排名可能会受到该季度会计异常的影响(如税收法律变化或...
• $Avantor (AVTR.US)$ :花旗集团从中立升级至买入-目标价28美元
• $丘奇&德怀特 (CHD.US)$ :德意志银行将评级从持有调升至买入 - 目标价$85(由$90)
• $康菲石油 (COP.US)$ Erste集团从持有升级为买入
• $福特汽车 (F.US)$ :摩根史坦利将评级从等权调升至超配 - 目标价$14
• $慧荣科技 (SIMO.US)$ :Susquehanna将评级从中立调升至正面 - 目标价$108
• $沃尔玛 (WMT.US)$ ...
• $博格华纳 (BWA.US)$ :德意志银行升级为买入,从持有-目标价$48(从$43)
• $Expensify (EXFY.US)$ :美银证券升级为买入,从中立-目标价$25(从$20)
• $Grab Holdings (GRAB.US)$ :摩根大通从中立升级为增持-目标价3美元
• $华利安 (HLI.US)$ :摩根史坦利从弱势升级为等权重-目标价82美元(从95美元)
• $摩根大通 (JPM.US)$ :贝融升级为持有,从卖出-目标价...
• $德希尼布FMC (FTI.US)$ : Societe Generale Upgrades to uy from Hold - Pt $10
• $Lululemon Athletica (LULU.US)$ : Truist Securities Upgrades to Buy from Hold - Pt $495 (from $390)
• $NorthWestern (NWE.US)$ 巴克莱银行将评级从低于标准调升至等权重-目标价$62(由$57提高)
• $波特兰通用电气 (POR.US)$ 巴克莱银行将评级从低于标准调升至等权重-目标价$57(由$53提高)
• $普尔斯玛特 (PSMT.US)$ :加拿大丰业银行升级为板块前景优秀…
暂无评论